We are pleased to announce the results of our latest #study, conducted in collaboration with HELLESCC | Hellenic Society of Crohn Disease And Ulcerative Colitis Patients. Our findings highlight a critical insight: a significant proportion of patients with...
Delighted to have been part of European Crohn’s and Colitis Organization in Berlin, Germany! We are happy to share that our research study, titled "Patient-reported outcomes in a Greek cross-sectional survey of inflammatory bowel disease patients treated with biologic...
Happy to share our most recent, open-access publication ”Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece ” in Value in Health Regional Issues. Ulcerative Colitis (UC) is a chronic inflammatory...
We are delighted to share our latest real-world evidence publication, titled "Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette–Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World...
Delighted to have been part of ISPOR—The Professional Society for Health Economics and Outcomes Research in Barcelona, Spain! Health Through Evidence proudly presented 15 research posters at ISPOR Europe 2024, highlighting impactful studies in Health Economics, Real...